EU pilot project to assess value of new drugs at an early stage
This article was originally published in SRA
The European Medicines Agency and stakeholders from six EU countries have launched a pilot project on assessing the therapeutic and economic value of new drugs at an early stage of their development1.
You may also be interested in...
Roche plans to appeal against a penalty imposed by the Romanian competition authorities for implementing strategies that were said to delay the entry of competing biosimilar and generic products.
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
The latest drug safety actions by the European Medicines Agency affect products for dermatological use and vaginal atrophy.